After yesterday's sharp declines, today's Wall Street opening brings a slight recovery. The main spot indices are gaining 0.60-0.70%, and futures on these indices are rebounding by over 2.00% due to contract rollovers. The dollar is slightly weakening but remains significantly above yesterday's pre-FOMC conference levels. Meanwhile, U.S. bond yields continue to rise. The strong upward trend is particularly evident in 10-year yields, which are approaching 4.56%.
US500
The US500 index lost nearly 3.00% after yesterday's Federal Reserve decision, marking its biggest one-day loss since August this year following the release of NFP data. The chart shows a precarious ascending triangle technical pattern, which typically signals a trend reversal. Yesterday's strong breakout below the lower support line may potentially indicate such a scenario is materializing. If this is the case, continued selling pressure should be expected. On the other hand, bulls are making an effort to defend the support level above 5930 points.
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile app
Source: xStation 5
Company Highlights
Sangamo Therapeutics (SGMO.US): Shares gained 4.30% after licensing its STAC-BBB capsid technology to Astellas Pharma for $20M upfront, up to $1.3B in milestones, and royalties, targeting neurological diseases.
Accenture (ACN.US) gains 0.70% as FQ1 results beat expectations, FY2025 revenue growth outlook was raised to 4%-7%, and plans to return $8.3B to shareholders boosted confidence.
Micron Technology (MU.US) dips 15% due to weak FQ2 guidance, with earnings ($1.33–$1.53/share) and revenue ($7.7B–$8.1B) below consensus, despite optimism for AI-driven growth.
Vertex Pharmaceuticals (VRTX.US) dropped 11.85% after trial results for its pain drug suzetrigine showed similar efficacy to placebo (-1.98 vs. -2.02), raising concerns despite plans for pivotal trials.
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
